文献速递胃肠外科围术期管理与 ERAS

术前糖尿病状态、循环GDF15与袖状胃切除术后体重减轻

Preoperative diabetes status, circulating GDF15, and weight loss after sleeve gastrectomy.
PubMed 文献 · Surg Endosc · 2026-10-09

这项前瞻性单中心观察性队列纳入105例重度肥胖行腹腔镜袖状胃切除术患者,按术前2型糖尿病状态分层。结果显示,GDF15在术后6个月升高、1年回落,且术前2型糖尿病患者基线GDF15更高但术后变化轨迹不同;基线GDF15独立预测1年总体重减轻百分比。

要点

  • 袖状胃切除术后GDF15在6个月升高、1年回落至基线。
  • 术前2型糖尿病患者基线GDF15更高,术后6个月短暂升高后1年回落。
  • 基线GDF15较高独立预测1年总体重减轻百分比较低。

核心结论

  • 袖状胃切除术后循环GDF15变化轨迹因术前2型糖尿病状态而异。
  • 基线GDF15可能有助于描述袖状胃切除术后代谢适应和体重减轻的个体差异。

研究设计与样本

  • 前瞻性单中心观察性队列,纳入105例重度肥胖行腹腔镜袖状胃切除术患者,手术时间2018年至2022年。
  • 术前、术后6个月和1年测量循环GDF15及临床变量,按术前2型糖尿病状态分层。
  • 采用逐步多变量线性回归评估基线GDF15与1年总体重减轻百分比(TWL%)的关联。

主要发现

  • 总体GDF15从术前699.3 ± 454.7 pg/mL升至术后6个月849.2 ± 596.2 pg/mL(p = 0.002),1年回落至739.3 ± 490.3 pg/mL(p = 0.327)。
  • 术前2型糖尿病患者基线GDF15为843.8 ± 503.4 pg/mL,高于无糖尿病者的557.5 ± 351.6 pg/mL(p = 0.001)。
  • 术前2型糖尿病患者GDF15在6个月短暂升至1020.6 ± 678.2 pg/mL(p = 0.018),1年回落至830.6 ± 581.5 pg/mL(p = 0.854)。
  • 无2型糖尿病患者GDF15在6个月(681.0 ± 449.0 pg/mL,p = 0.037)和1年(649.7 ± 364.3 pg/mL,p = 0.022)持续升高。
  • 平均1年TWL%为32.1 ± 7.7%,多变量分析中较高基线GDF15独立预测较低1年TWL%。

临床怎么用

  • 术前可检测GDF15以辅助评估袖状胃切除术后体重减轻的个体差异。
  • 对合并2型糖尿病的患者,应关注其术后GDF15的短暂升高模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Growth differentiation factor 15 (GDF15) is a stress-responsive cytokine implicated in metabolic stress, appetite regulation, and energy homeostasis. However, longitudinal GDF15 changes after metabolic bariatric surgery remain inconsistent, and whether preoperative type 2 diabetes (T2D) modifies postoperative GDF15 trajectories after sleeve gastrectomy (SG) is unclear. METHODS: In this prospective, single-center observational cohort, 105 patients with severe obesity undergoing laparoscopic SG between 2018 and 2022 were studied. Circulating GDF15 and clinical variables were measured preoperatively and at 6 months and 1 year after SG. Patients were stratified by preoperative T2D status. Associations between baseline GDF15 and 1-year total weight loss percentage (TWL%) were assessed using stepwise multivariable linear regression. RESULTS: Participants were 53 males, mean age 39.3 ± 10.4 years, and BMI 40.4 ± 5.4 kg/m2; 52 had preoperative T2D. GDF15 increased at 6 months after SG (699.3 ± 454.7 to 849.2 ± 596.2 pg/mL, p = 0.002) but returned toward baseline at 1 year (739.3 ± 490.3 pg/mL, p = 0.327). Patients with preoperative T2D had higher baseline GDF15 levels compared to those without diabetes (843.8 ± 503.4 vs. 557.5 ± 351.6 pg/mL, p = 0.001), with a transient increase at 6 months (1020.6 ± 678.2 pg/mL, p = 0.018) that returned to baseline at 1 year (830.6 ± 581.5 pg/mL, p = 0.854). In contrast, patients without T2D exhibited a sustained increase of GDF15 levels at 6 months (681.0 ± 449.0 pg/mL, p = 0.037) and 1 year (649.7 ± 364.3 pg/mL, p = 0.022). Mean 1-year TWL% was 32.1 ± 7.7%. Higher baseline GDF15 independently predicted lower 1-year TWL% in multivariate analyses. CONCLUSIONS: After SG, circulating GDF15 follows distinct trajectories according to preoperative T2D status. Baseline GDF15 may help characterize individual variability in metabolic adaptation and weight loss after SG.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lee YY, Lin YJ, Yang WS, et al. Preoperative diabetes status, circulating GDF15, and weight loss after sleeve gastrectomy. Surg Endosc. 2026. PMID: 42855511. doi:10.1007/s00464-026-13491-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。